Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Subvariant Neutralization Following a Primary Vaccine Series of NVX-CoV2373 and BNT162b2 Monovalent Booster Vaccine.
- Resource Type
- Case Study
- Source
Open Forum Infectious Diseases . Feb2024, Vol. 11 Issue 2, p1-4. 4p.- Subject
- *
SARS-CoV-2
*BOOSTER vaccines
*SARS-CoV-2 Omicron variant
*COVID-19 vaccines
*VACCINES - Language
- ISSN
- 2328-8957